Somatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute Cohort
Sun T, Wang X, Wang M, Minerowicz C, Sanchez H, Laskin W, Cohen P, Zhong M. Somatic Mutation of BAP1 Can Lead to Expression Loss in Non-Small Cell Lung Carcinoma: Next Generation Sequencing and IHC Analysis in A Large Single Institute Cohort. International Journal Of Surgical Pathology 2021, 30: 512-519. PMID: 34970936, DOI: 10.1177/10668969211070179.Peer-Reviewed Original ResearchConceptsNon-small cell lung carcinomaCell lung carcinomaLung carcinomaCell carcinomaSomatic mutationsClear cell renal cell carcinomaExpression lossCell renal cell carcinomaSquamous cell carcinomaNext-generation sequencingGenetic alterationsRenal cell carcinomaBAP1 protein expressionProtein expression statusStudy cohortNSCLC casesNSCLC tumorsLoss of expressionNeural tumorsAdditional genetic alterationsCommon findingIHC analysisNSCLC carcinogenesisIRB approvalMelanocytic tumorsDiagnostic value of a comprehensive, urothelial carcinoma–specific next‐generation sequencing panel in urine cytology and bladder tumor specimens
Sun T, Hutchinson L, Tomaszewicz K, Caporelli M, Meng X, McCauley K, Fischer AH, Cosar EF, Cornejo KM. Diagnostic value of a comprehensive, urothelial carcinoma–specific next‐generation sequencing panel in urine cytology and bladder tumor specimens. Cancer Cytopathology 2021, 129: 537-547. PMID: 33539671, DOI: 10.1002/cncy.22410.Peer-Reviewed Original ResearchConceptsLow-grade urothelial carcinomaHigh-grade urothelial carcinomaUrine cytology specimensUrothelial carcinomaCytology specimensDiagnostic utilityUrine cytologyNGS panelNext-generation sequencing panelHigh-grade tumorsNext-generation sequencingBiopsy/resectionPossible diagnostic utilityTumor biopsy/resectionCancer Genome AtlasBladder tumorsResection specimensSurgical specimensThinPrep cytologySequencing panelHGUC casesDiagnostic valueCarcinomaCytologyPilot study